002004 华邦健康
交易中 08-03 11:12:33
资讯
新帖
简况
华邦健康(002004.SZ)获得伊布替尼片药品注册证书
智通财经 · 07-31 16:15
华邦健康(002004.SZ)获得伊布替尼片药品注册证书
凯盛新材:公司控股股东华邦健康基于自身规划发行可交换公司债券
证券之星 · 07-24
凯盛新材:公司控股股东华邦健康基于自身规划发行可交换公司债券
股市必读:华邦健康(002004)6月22日董秘有最新回复
证券之星 · 06-23
股市必读:华邦健康(002004)6月22日董秘有最新回复
每周股票复盘:华邦健康(002004)子公司补税及罚款超7678万
证券之星 · 06-21
每周股票复盘:华邦健康(002004)子公司补税及罚款超7678万
华邦健康:公司目前经营管理正常
证券之星 · 06-17
华邦健康:公司目前经营管理正常
华邦健康(002004)披露全资子公司收到《税务事项通知书》的进展公告,6月16日股价下跌2.27%
证券之星 · 06-16
华邦健康(002004)披露全资子公司收到《税务事项通知书》的进展公告,6月16日股价下跌2.27%
华邦健康:张一卓在华邦旗下医疗事业部任执行董事
证券之星 · 06-11
华邦健康:张一卓在华邦旗下医疗事业部任执行董事
华邦健康:公司目前经营正常
证券之星 · 06-11
华邦健康:公司目前经营正常
华邦健康(002004)披露控股股东部分股份质押公告,5月28日股价下跌0.44%
证券之星 · 05-28
华邦健康(002004)披露控股股东部分股份质押公告,5月28日股价下跌0.44%
华邦健康(002004)股东重庆汇邦卓远科技有限公司质押3800万股,占总股本1.92%
证券之星 · 05-28
华邦健康(002004)股东重庆汇邦卓远科技有限公司质押3800万股,占总股本1.92%
华邦健康(002004)披露2025年年度股东会决议公告,5月15日股价下跌0.62%
证券之星 · 05-15
华邦健康(002004)披露2025年年度股东会决议公告,5月15日股价下跌0.62%
华邦健康最新公告:全资子公司获乌帕替尼缓释片药品注册证书
证券之星 · 05-07
华邦健康最新公告:全资子公司获乌帕替尼缓释片药品注册证书
华邦健康(002004)披露全资子公司收到《税务事项通知书》,5月6日股价下跌1.61%
证券之星 · 05-06
华邦健康(002004)披露全资子公司收到《税务事项通知书》,5月6日股价下跌1.61%
股市必读:华邦健康一季报 - 第一季度单季净利润同比下降16.01%
证券之星 · 04-27
股市必读:华邦健康一季报 - 第一季度单季净利润同比下降16.01%
华邦健康(002004)3月31日股东户数7.18万户,较上期增加2.75%
证券之星 · 04-25
华邦健康(002004)3月31日股东户数7.18万户,较上期增加2.75%
华邦健康(002004.SZ)发布一季度业绩,归母净利润1.55亿元,同比下降16.01%
智通财经网 · 04-24
华邦健康(002004.SZ)发布一季度业绩,归母净利润1.55亿元,同比下降16.01%
华邦健康(002004)3月31日股东户数7.18万户,较上期增加2.75%
证券之星 · 04-23
华邦健康(002004)3月31日股东户数7.18万户,较上期增加2.75%
图解华邦健康年报:第四季度单季净利润同比增长113.50%
证券之星 · 04-23
图解华邦健康年报:第四季度单季净利润同比增长113.50%
华邦健康(002004)披露证券事务代表辞职公告,4月16日股价上涨0.57%
证券之星 · 04-16
华邦健康(002004)披露证券事务代表辞职公告,4月16日股价上涨0.57%
华邦健康:3月25日接受机构调研,包括知名机构高毅资产的多家机构参与
证券之星 · 03-26
华邦健康:3月25日接受机构调研,包括知名机构高毅资产的多家机构参与
加载更多
公司概况
公司名称:
华邦生命健康股份有限公司
所属行业:
化学原料和化学制品制造业
上市日期:
2004-06-25
主营业务:
华邦生命健康股份有限公司的主营业务是医药制剂及原料药的研发、生产和销售、运营医疗机构,以及从事医疗配套供应链服务、农药原药、中间体及制剂产品的研发、生产、销售、GLP登记注册技术服务及生物技术研究开发、精细化工产品及新型高分子材料的研发、生产和销售、旅游业务。公司的主要产品是医药产品、农化新材料、旅游服务、医疗。
发行价格:
9.60
{"stockData":{"symbol":"002004","market":"SZ","secType":"STK","nameCN":"华邦健康","latestPrice":4.51,"timestamp":1785726753000,"preClose":4.43,"halted":0,"volume":11363864,"delay":0,"changeRate":0.0181,"floatShares":1882999999,"shares":1980000000,"eps":0.3454,"marketStatus":"交易中","change":0.08,"latestTime":"08-03 11:12:33","open":4.43,"high":4.53,"low":4.42,"amount":51086000,"amplitude":0.0248,"askPrice":4.52,"askSize":4634,"bidPrice":4.51,"bidSize":2622,"shortable":0,"etf":0,"ttmEps":0.3454,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1785727800000},"marketStatusCode":2,"adr":0,"adjPreClose":4.43,"symbolType":"stock","openAndCloseTimeList":[[1785720600000,1785727800000],[1785733200000,1785740400000]],"highLimit":4.87,"lowLimit":3.99,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1979919191,"isCdr":false,"pbRate":0.84,"roa":"--","peRate":13.057325,"roe":"1.51%","epsLYR":0.3615,"committee":-0.2629,"marketValue":8929000000,"turnoverRate":0.006,"status":0,"floatMarketCap":8494000000},"requestUrl":"/m/hq/s/002004/","defaultTab":"news","newsList":[{"id":"2655092355","title":"华邦健康(002004.SZ)获得伊布替尼片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2655092355","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2655092355?lang=zh_cn&edition=full","pubTime":"2026-07-31 16:15","pubTimestamp":1785485726,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华邦健康(002004.SZ)发布公告,公司全资子公司重庆华邦制药有限公司(以下简称“华邦制药”)于近日收到国家药品监督管理局核准签发的关于伊布替尼片的《药品注册证书》。伊布替尼片按化学药品3类申报,视同通过仿制药质量和疗效一致性评价。该产品的正式获批,将进一步丰富公司抗肿瘤领域的产品管线布局,同时为临床患者提供更多优质用药选择。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1474569.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0042","BK0188","BK0229","BK0174","BK0146","BK0114","002004"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653704344","title":"凯盛新材:公司控股股东华邦健康基于自身规划发行可交换公司债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2653704344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653704344?lang=zh_cn&edition=full","pubTime":"2026-07-24 15:18","pubTimestamp":1784877499,"startTime":"0","endTime":"0","summary":"证券之星消息,凯盛新材(301069)07月24日在投资者关系平台上答复投资者关心的问题。投资者提问:请问控股股东华邦健康一直发行可转债变现减持是什么原因?公司是否有被国企收购的计划?凯盛新材回复:您好!公司控股股东华邦健康基于自身规划发行可交换公司债券。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400021276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002004","BK0114","BK0229","301069","BK0174","BK0146","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645807480","title":"股市必读:华邦健康(002004)6月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2645807480","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645807480?lang=zh_cn&edition=full","pubTime":"2026-06-23 02:05","pubTimestamp":1782151513,"startTime":"0","endTime":"0","summary":"公司公告汇总关于控股股东部分股份解除质押的公告华邦生命健康股份有限公司于2026年6月22日发布公告,公司控股股东重庆汇邦卓远科技有限公司于2026年6月17日将其持有的25,400,000股公司股份解除质押,占其所持股份比例6.86%,占公司总股本比例1.28%,质权人为中国银河证券股份有限公司。截至公告披露日,汇邦卓远及其一致行动人张松山、张一卓、赵丹琳合计持有公司股份543,010,887股,累计质押股份249,520,000股,占其所持股份比例45.95%,占公司总股本比例12.60%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300000954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0174","BK0229","BK0188","002004","BK0146","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645096479","title":"每周股票复盘:华邦健康(002004)子公司补税及罚款超7678万","url":"https://stock-news.laohu8.com/highlight/detail?id=2645096479","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645096479?lang=zh_cn&edition=full","pubTime":"2026-06-21 03:26","pubTimestamp":1781983573,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,华邦健康报收于4.12元,较上周的4.62元下跌10.82%。本周,华邦健康6月15日盘中最高价报4.66元。本周关注点公司公告汇总:全资子公司新马药业需补缴税款及罚款合计超7678万元。华邦生命健康股份有限公司控股股东重庆汇邦卓远科技有限公司将其持有的22,500,000股公司股份质押给中信建投证券股份有限公司,占其所持股份比例6.07%,占公司总股本比例1.14%,质押用途为融资需要。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100001140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK0188","BK0174","BK0146","BK0042","002004","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644797154","title":"华邦健康:公司目前经营管理正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2644797154","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644797154?lang=zh_cn&edition=full","pubTime":"2026-06-17 11:34","pubTimestamp":1781667278,"startTime":"0","endTime":"0","summary":"证券之星消息,华邦健康06月17日在投资者关系平台上答复投资者关心的问题。请问贵公司股票一直表现不好?请回答下谢谢华邦健康回复:投资者您好,公司目前经营管理正常,但股价受宏观环境、经营情况、投资者偏好等多种因素共同影响。未来,公司将依法依规运用各类方式提升公司投资价值,努力推动投资价值合理反应公司质量;同时踏实做好自身经营,持续提升内在价值,努力为股东创造长期价值,回报广大投资者的支持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700016847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK0114","BK0188","BK0174","BK0146","002004","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643763720","title":"华邦健康(002004)披露全资子公司收到《税务事项通知书》的进展公告,6月16日股价下跌2.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643763720","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643763720?lang=zh_cn&edition=full","pubTime":"2026-06-16 22:34","pubTimestamp":1781620458,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘,华邦健康报收于4.31元,较前一交易日下跌2.27%,最新总市值为85.33亿元。该股当日开盘4.41元,最高4.41元,最低4.3元,成交额达9703.09万元,换手率为1.19%。近日,华邦健康披露《关于全资子公司收到〈税务事项通知书〉的进展公告》。因案件尚未结束,暂不处罚,后续是否行政处罚视刑事程序结果而定。公司表示该事项暂未对整体经营造成重大不利影响,将积极配合调查,并根据进展履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600044309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0042","BK0146","002004","BK0174","BK0229","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642240758","title":"华邦健康:张一卓在华邦旗下医疗事业部任执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2642240758","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642240758?lang=zh_cn&edition=full","pubTime":"2026-06-11 16:12","pubTimestamp":1781165545,"startTime":"0","endTime":"0","summary":"证券之星消息,华邦健康(002004)06月11日在投资者关系平台上答复投资者关心的问题。投资者提问:请问张松山之子张一卓在华邦系旗下任什么职务,2024年和2025年的年薪分别是多少?华邦健康回复:投资者您好,张一卓在华邦旗下医疗事业部任执行董事,感谢您的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061100024788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0229","002004","BK0146","159891","BK0174","BK0114","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642140789","title":"华邦健康:公司目前经营正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2642140789","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642140789?lang=zh_cn&edition=full","pubTime":"2026-06-11 16:07","pubTimestamp":1781165220,"startTime":"0","endTime":"0","summary":"证券之星消息,华邦健康06月11日在投资者关系平台上答复投资者关心的问题。请回答下谢谢华邦健康回复:投资者您好,公司目前经营正常,也积极通过多种方式与投资者交流,但股价受宏观环境、经营情况、投资者偏好等多种因素共同影响。未来,公司将依法依规运用各类方式提升公司投资价值,努力推动投资价值合理反应公司质量;同时踏实做好自身经营,持续提升内在价值,努力为股东创造长期价值,回报广大投资者的支持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061100024192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0174","BK0114","002004","BK0146","BK0188","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638694499","title":"华邦健康(002004)披露控股股东部分股份质押公告,5月28日股价下跌0.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638694499","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638694499?lang=zh_cn&edition=full","pubTime":"2026-05-28 22:53","pubTimestamp":1779979991,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘,华邦健康报收于4.49元,较前一交易日下跌0.44%,最新总市值为88.9亿元。近日,华邦生命健康股份有限公司披露《关于控股股东部分股份质押的公告》。本次质押股份占其所持股份比例为10.26%,占公司总股本比例为1.92%。截至公告日,汇邦卓远及其一致行动人累计质押股份292,120,000股,占其合计持股的53.80%,占公司总股本的14.75%。相关股份不存在业绩补偿义务,质押未对公司生产经营造成不利影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800043616.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002004","BK0114","BK0146","BK0042","BK0229","BK0188","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638662584","title":"华邦健康(002004)股东重庆汇邦卓远科技有限公司质押3800万股,占总股本1.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638662584","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638662584?lang=zh_cn&edition=full","pubTime":"2026-05-28 18:23","pubTimestamp":1779963813,"startTime":"0","endTime":"0","summary":"证券之星消息,华邦健康5月28日公开信息显示,股东重庆汇邦卓远科技有限公司向渤海国际信托股份有限公司合计质押3800.0万股,占总股本1.92%。质押详情见下表:截止本公告日,股东重庆汇邦卓远科技有限公司已累计质押股份2.4亿股,占其持股总数的64.82%,股东张松山已累计质押股份2991.0万股,占其持股总数的25.54%,股东张一卓已累计质押股份2208.0万股,占其持股总数的40.1%。华邦健康主营业务:农药、医药、化学原料药、医疗健康、旅游服务业等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800035576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0042","BK0188","BK0229","002004","BK0114","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635033188","title":"华邦健康(002004)披露2025年年度股东会决议公告,5月15日股价下跌0.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635033188","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635033188?lang=zh_cn&edition=full","pubTime":"2026-05-15 22:34","pubTimestamp":1778855656,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,华邦健康报收于4.77元,较前一交易日下跌0.62%,最新总市值为94.44亿元。华邦生命健康股份有限公司于2026年5月15日召开2025年年度股东会,审议通过了《2025年度董事会工作报告》《2025年度财务决算报告》《2025年度利润分配预案》《2025年年度报告》及其摘要、续聘2026年度审计机构、使用暂时闲置募集资金进行现金管理、修订《公司章程》及部分公司治理制度、董事及高管薪酬管理制度等相关议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500044276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0042","BK0229","BK0174","002004","BK0114","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633144683","title":"华邦健康最新公告:全资子公司获乌帕替尼缓释片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2633144683","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633144683?lang=zh_cn&edition=full","pubTime":"2026-05-07 20:00","pubTimestamp":1778155237,"startTime":"0","endTime":"0","summary":"华邦健康(002004.SZ)公告称,公司全资子公司重庆华邦制药近日收到国家药品监督管理局核准签发的乌帕替尼缓释片《药品注册证书》。该药品为化学药品4类,视同通过仿制药一致性评价,适用于特应性皮炎、类风湿关节炎、银屑病关节炎、溃疡性结肠炎、克罗恩病等多种适应症。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700037118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK0188","BK0174","BK0146","BK0042","002004","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633181712","title":"华邦健康(002004)披露全资子公司收到《税务事项通知书》,5月6日股价下跌1.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633181712","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633181712?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:45","pubTimestamp":1778064318,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘,华邦健康报收于4.89元,较前一交易日下跌1.61%,最新总市值为96.82亿元。公司于近日披露《关于全资子公司收到〈税务事项通知书〉的公告》。公告显示,华邦健康全资子公司沈阳新马药业收到国家税务总局沈阳市税务局第二稽查局出具的《税务事项通知书》,拟认定其2019年1月1日至2024年12月31日期间涉税问题,需补缴增值税及附加5,071,698.08元、企业所得税41,249,955.29元,并加征滞纳金,拟处罚款46,095,238.28元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600032581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0114","002004","BK0146","BK0042","BK0229","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630339844","title":"股市必读:华邦健康一季报 - 第一季度单季净利润同比下降16.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630339844","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630339844?lang=zh_cn&edition=full","pubTime":"2026-04-27 04:16","pubTimestamp":1777234572,"startTime":"0","endTime":"0","summary":"来自股本股东变化:截至2026年3月31日,华邦健康股东户数达7.18万户,较上期增长2.75%。业绩披露要点财务报告华邦健康2026年一季报显示,一季度主营收入28.19亿元,同比下降0.08%;归母净利润1.55亿元,同比下降16.01%;扣非净利润1.43亿元,同比下降16.05%;负债率41.89%,投资收益1936.83万元,财务费用7434.23万元,毛利率35.87%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700005796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002004"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630487035","title":"华邦健康(002004)3月31日股东户数7.18万户,较上期增加2.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630487035","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630487035?lang=zh_cn&edition=full","pubTime":"2026-04-25 17:08","pubTimestamp":1777108137,"startTime":"0","endTime":"0","summary":"证券之星消息,近日华邦健康披露,截至2026年3月31日公司股东户数为7.18万户,较12月31日增加1918.0户,增幅为2.75%。在化学制药行业个股中,华邦健康股东户数高于行业平均水平,截至3月31日,化学制药行业平均股东户数为3.52万户。从股价来看,2025年12月31日至2026年3月31日,华邦健康区间涨幅为9.41%,在此期间股东户数增加1918.0户,增幅为2.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500032404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK0114","BK0188","BK0174","BK0146","002004","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629495188","title":"华邦健康(002004.SZ)发布一季度业绩,归母净利润1.55亿元,同比下降16.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629495188","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629495188?lang=zh_cn&edition=full","pubTime":"2026-04-24 20:16","pubTimestamp":1777033010,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华邦健康(002004.SZ)发布2026年第一季度报告,第一季度,公司实现营业收入28.19亿元,同比下降0.08%。归属于上市公司股东的净利润1.55亿元,同比下降16.01%。归属于上市公司股东的扣除非经常性损益的净利润1.43亿元,同比下降16.05%。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433664.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["002004"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629488458","title":"华邦健康(002004)3月31日股东户数7.18万户,较上期增加2.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629488458","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629488458?lang=zh_cn&edition=full","pubTime":"2026-04-23 17:31","pubTimestamp":1776936700,"startTime":"0","endTime":"0","summary":"证券之星消息,近日华邦健康披露,截至2026年3月31日公司股东户数为7.18万户,较12月31日增加1918.0户,增幅为2.75%。在化学制药行业个股中,华邦健康股东户数高于行业平均水平,截至3月31日,化学制药行业平均股东户数为3.5万户。从股价来看,2025年12月31日至2026年3月31日,华邦健康区间涨幅为9.41%,在此期间股东户数增加1918.0户,增幅为2.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300048189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0174","BK0146","BK0229","BK0042","BK0114","002004"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629029039","title":"图解华邦健康年报:第四季度单季净利润同比增长113.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629029039","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629029039?lang=zh_cn&edition=full","pubTime":"2026-04-23 01:33","pubTimestamp":1776879208,"startTime":"0","endTime":"0","summary":"证券之星消息,华邦健康2025年年报显示,当年度公司主营收入115.12亿元,同比下降1.31%;归母净利润7.13亿元,同比上升338.53%;扣非净利润6.43亿元,同比上升290.35%;其中2025年第四季度,公司单季度主营收入24.26亿元,同比下降11.92%;单季度归母净利润1.01亿元,同比上升113.5%;单季度扣非净利润9086.74万元,同比上升111.74%;负债率41.51%,投资收益6032.37万元,财务费用2.76亿元,毛利率36.92%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300003040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002004"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627962102","title":"华邦健康(002004)披露证券事务代表辞职公告,4月16日股价上涨0.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627962102","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627962102?lang=zh_cn&edition=full","pubTime":"2026-04-16 17:45","pubTimestamp":1776332753,"startTime":"0","endTime":"0","summary":"截至2026年4月16日收盘,华邦健康报收于5.26元,较前一交易日上涨0.57%,最新总市值为104.14亿元。近日,华邦生命健康股份有限公司发布《关于公司证券事务代表辞职的公告》。公告显示,公司董事会于近日收到证券事务代表陈志先生提交的书面辞职报告。陈志先生因个人原因申请辞去公司证券事务代表职务,辞职报告自送达董事会之日起生效,辞职后不再担任公司其他职务。公司董事会将根据相关规定尽快完成证券事务代表的聘任工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600032325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0042","BK0114","002004","BK0174","BK0229","BK0188","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622861918","title":"华邦健康:3月25日接受机构调研,包括知名机构高毅资产的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2622861918","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622861918?lang=zh_cn&edition=full","pubTime":"2026-03-26 08:34","pubTimestamp":1774485278,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年3月25日华邦健康发布公告称公司于2026年3月25日接受机构调研,宝盈基金、财通证券、高毅资产、华夏基金、民生加银基金、鹏华基金、信达澳亚基金参与。原料药公司拥有重庆合川、长寿及陕西汉中三大原料药生产基地。同时,公司参股了专注于细胞基因治疗药物的新三板挂牌公司普瑞金,目前通过直接和间接方式合计持有普瑞金13.2%股权,是普瑞金的第三大股东。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600009296.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK0188","BK0174","BK0146","BK0042","002004","BK0114"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1785726757012,"stockEarnings":[{"period":"1week","weight":0.0548},{"period":"1month","weight":0.0993},{"period":"3month","weight":-0.0582},{"period":"6month","weight":-0.1643},{"period":"1year","weight":0.1139},{"period":"ytd","weight":-0.0208}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":-0.0681},{"period":"3month","weight":-0.0681},{"period":"6month","weight":-0.0694},{"period":"1year","weight":0.0725},{"period":"ytd","weight":-0.0344}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华邦生命健康股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"71767人(较上一季度减少53.60%)","perCapita":"26242股","listingDate":"2004-06-25","address":"重庆市两江新区人和星光大道69号","registeredCapital":"197991万元","survey":" 华邦生命健康股份有限公司的主营业务是医药制剂及原料药的研发、生产和销售、运营医疗机构,以及从事医疗配套供应链服务、农药原药、中间体及制剂产品的研发、生产、销售、GLP登记注册技术服务及生物技术研究开发、精细化工产品及新型高分子材料的研发、生产和销售、旅游业务。公司的主要产品是医药产品、农化新材料、旅游服务、医疗。","listedPrice":9.6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华邦健康(002004)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华邦健康(002004)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华邦健康,002004,华邦健康股票,华邦健康股票老虎,华邦健康股票老虎国际,华邦健康行情,华邦健康股票行情,华邦健康股价,华邦健康股市,华邦健康股票价格,华邦健康股票交易,华邦健康股票购买,华邦健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华邦健康(002004)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华邦健康(002004)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}